GleamWall
中文EN

MRM Medirom Healthcare Technologies Inc. Annual reports only

Services-Personal Services · Nasdaq · SEC CIK 1819704 · Reporting currency JPY · Fiscal year ends 12/31

Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY21.5%
TTM net income YoY28.9%
TTM EPS YoY27.7%
Revenue 3-yr CAGR15.3%
Net income 3-yr CAGR—

Margins

Gross margin27.1%
Operating margin-0.2%
Net margin1.8%
FCF margin-16.9%
EBITDA margin3.3%

Returns

ROE26.0%
ROA2.0%
ROIC (approx.)-1.1%
Asset turnover1.11x

Leverage & solvency

Liabilities / assets85.3%
Debt / equity1.48x
Current ratio0.65x
Interest coverage-0.36x

Cash quality & payout

Operating cash flow / net income-8.95x
Accruals ratio19.8%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: JPY FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue6.23B8.30B6.83B6.95B5.41B
Cost of revenue—6.05B5.26B5.05B—
Gross profit—2.25B1.57B1.90B—
SG&A expense2.57B2.24B1.96B1.81B1.82B
Operating income-3.39B-18.10M-391.58M96.97M-470.59M
Interest expense66.19M49.74M36.87M9.80M11.95M
Pretax income-3.34B47.71M20.62M179.77M-414.48M
Income tax304.12M-90.48M-94.43M30.81M576.25M
Net income-3.63B148.76M115.40M148.97M-990.73M
EBITDA-2.86B271.94M-138.98M281.02M-344.34M
EPS (basic)-459.9229.1323.6430.54-203.13
EPS (diluted)-459.9228.5222.3427.23-203.13
Weighted avg. shares (diluted)7.90M5.85M5.17M5.47M4.88M
Balance sheet
Cash & equivalents91.98M329.40M106.35M605.45M370.62M
Short-term investments6.16M6.16M26.50M26.50M26.53M
Receivables671.66M1.36B621.87M534.69M312.30M
Inventory156.62M151.64M139.98M114.11M18.70M
Current assets1.49B2.71B1.76B2.36B1.38B
PP&E, net154.62M435.66M451.50M424.29M425.00M
Goodwill0389.13M484.56M539.49M600.33M
Intangibles862.65M1.14B920.70M403.67M391.04M
Total assets4.68B8.09B6.85B6.75B5.75B
Current liabilities4.73B4.18B3.56B3.64B3.20B
Short-term debt161.32M620.81M100.42M99.17M162.25M
Long-term debt799.96M764.20M1.05B1.15B746.59M
Total debt961.28M1.39B1.15B1.25B908.84M
Total liabilities7.11B6.90B6.63B6.81B5.96B
Shareholders' equity-2.67B933.27M210.88M-59.38M-208.34M
Net debt869.30M1.06B1.04B643.48M538.22M
Shares outstanding7.90M2,024———
Cash flow statement
Operating cash flow-1.16B-1.33B-631.74M-685.70M-557.23M
Capital expenditure10.30M71.41M135.84M120.74M95.65M
Free cash flow-1.17B-1.40B-767.58M-806.44M-652.88M
Investing cash flow-22.46M361.39M-328.58M580.44M-83.94M
Financing cash flow940.04M1.19B461.21M340.10M-427.95M
Depreciation & amortization532.66M290.04M252.59M184.06M126.24M
Stock-based compensation0———196.85M

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· Amounts are in the company's reporting currency, JPY, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.